Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
American Journal of Physiology. Heart and Circulatory Physiology|July 11, 2012
Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac functionToshio Nagai, Issei KomuroMethods in Molecular Biology (Clifton, N.J.)|June 29, 2013
Cardiac side population cells and Sca-1-positive cellsToshio Nagai, Katsuhisa Matsuura, Issei KomuroDrugs of Today (Barcelona, Spain : 1998)|July 16, 2003
The role of PPARgamma-dependent pathway in the development of cardiac hypertrophyHiroyuki Takano, Hiroshi Hasegawa, Toshio Nagai, et al.Timely Topics in Medicine. Cardiovascular Diseases|April 15, 2005
The role of PPARgamma-dependent pathway in the development of cardiac hypertrophyHiroyuki Takano, Hiroshi Hasegawa, Toshio Nagai, et al.Internal Medicine (Tokyo, Japan)|July 15, 2003
Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategiesHiroyuki Takano, Hiroshi Hasegawa, Toshio Nagai, et al.Antioxidants & Redox Signaling|November 1, 2003
Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseasesHiroyuki Takano, Yunzeng Zou, Hiroshi Hasegawa, et al.Endocrine Journal|May 15, 2002
Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophyYunzeng Zou, Hiroyuki Takano, Hiroshi Akazawa, et al.The Journal of Cell Biology|February 6, 2004
A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5Hiroshi Akazawa, Sumiyo Kudoh, Naoki Mochizuki, et al.Progress in Biophysics and Molecular Biology|May 7, 2003
Stretch-modulation of second messengers: effects on cardiomyocyte ion transportSumiyo Kudoh, Hiroshi Akazawa, Hiroyuki Takano, et al.Journal of Molecular and Cellular Cardiology|July 25, 2003
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in ratsHiroshi Hasegawa, Rie Yamamoto, Hiroyuki Takano, et al.Pageof 5